Table 1 Baseline characteristics of patients
Time to CR | P-value | |||
|---|---|---|---|---|
< 6 m (n = 78) | 6-9 m (n = 12) | > 9 m (n = 16) | ||
Age (years) | 31.9 ± 4.3 | 31.2 ± 3.8 | 31.4 ± 4.1 | 0.833 |
BMI (kg/m2) | 25.8 ± 4.4 | 27.1 ± 5.6 | 26.9 ± 3.9 | 0.561 |
HOMA-IR | 3.4 ± 2.7 | 3.7 ± 2.6 | 4.8 ± 3.3 | 0.212 |
FBG (mmol/L) | 5.0 ± 1.0 | 5.3 ± 1.5 | 7.0 ± 8.8 | 0.886 |
Serum insulin (μU/mL) | 15.2 ± 10.5 | 16.1 ± 10.2 | 20.0 ± 14.7 | 0.455 |
HDL (mmol/L) | 1.13 ± 0.02 | 1.13 ± 0.09 | 1.23 ± 0.16 | 0.442 |
Triglyceride(mmol/L) | 1.61 ± 0.12 | 1.38 ± 0.19 | 1.90 ± 0.35 | 0.152 |
Following time (months) | 35.2 ± 29.7 | 42.0 ± 23.2 | 34.9 ± 35.1 | 0.450 |
IR | 0.547 | |||
No | 41 (52.6%) | 6 (50.0%) | 6 (37.5%) | |
Yes | 37 (47.4%) | 6 (50.0%) | 10 (62.5%) | |
DM | 0.416 | |||
No | 61 (78.2%) | 8 (66.7%) | 14 (87.5%) | |
Yes | 17 (21.8%) | 4 (33.3%) | 2 (12.5%) | |
HBP | 1.000 | |||
No | 72 (92.3%) | 11 (91.7%) | 15 (93.8%) | |
Yes | 6 (7.7%) | 1 (8.3%) | 1 (6.2%) | |
MetS | 0.187 | |||
No | 68 (87.2%) | 10 (83.3%) | 11 (68.8%) | |
Yes | 10 (12.8%) | 2 (16.7%) | 5 (31.2%) | |
PCOS | 0.008 | |||
No | 46 (59.0%) | 8 (66.7%) | 3 (18.8%) | |
Yes | 32 (41.0%) | 4 (33.3%) | 13 (81.2%) | |
Gestation | 0.416 | |||
No | 45 (57.7%) | 9 (75.0%) | 11 (68.8%) | |
Yes | 33 (42.3%) | 3 (25.0%) | 5 (31.2%) | |
Parity | 0.080 | |||
No | 61 (78.2%) | 12 (100.0%) | 15 (93.8%) | |
Yes | 17 (21.8%) | 0 (0.0%) | 1 (6.2%) | |
Infertility | 0.908 | |||
No | 42 (53.8%) | 7 (58.3%) | 8 (50.0%) | |
Yes | 36 (46.2%) | 5 (41.7%) | 8 (50.0%) | |
Histological type | 0.227 | |||
AEH | 47 (60.3%) | 6 (50.0%) | 6 (37.5%) | |
Early EC | 31 (39.7%) | 6 (50.0%) | 10 (62.5%) | |
Metformin | 0.950 | |||
No | 42 (53.8%) | 7 (58.3%) | 9 (56.2%) | |
Yes | 36 (46.2%) | 5 (41.7%) | 7 (43.8%) | |
MPA250mg | 0.448 | |||
No | 31 (39.7%) | 7 (58.3%) | 6 (37.5%) | |
Yes | 47 (60.3%) | 5 (41.7%) | 10 (62.5%) | |
MPA500mg | 0.521 | |||
No | 63 (80.8%) | 8 (66.7%) | 13 (81.2%) | |
Yes | 15 (19.2%) | 4 (33.3%) | 3 (18.8%) | |
MA | 0.148 | |||
No | 68 (87.2%) | 9 (75.0%) | 11 (68.8%) | |
Yes | 10 (12.8%) | 3 (25.0%) | 5 (31.2%) | |
GnRH-a | 0.907 | |||
No | 68 (87.2%) | 11 (91.7%) | 14 (87.5%) | |
Yes | 10 (12.8%) | 1 (8.3%) | 2 (12.5%) | |
Recurrence | 0.365 | |||
No | 49 (62.8%) | 8 (66.7%) | 13 (81.2%) | |
Yes | 29 (37.2%) | 4 (33.3%) | 3 (18.8%) | |